Laura Sutcliffe
Stock Analyst at Citi
(2.48)
# 2,960
Out of 4,421 analysts
482
Total ratings
51.2%
Success rate
1%
Average return
Main Sectors:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Rated: Buy | $340 → $270 | $188.63 | +43.14% | 13 | Jun 15, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | $48.00 → $38.00 | $26.72 | +42.22% | 19 | Jun 15, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Maintained: Hold | n/a | $38.37 | - | 6 | May 27, 2026 | |
| ASX: CSL CSL Limited | Maintained: Hold | $110.00 | $111.37 | -1.23% | 35 | May 14, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $32.00 | $14.51 | +120.54% | 31 | Apr 29, 2026 | |
| ASX: COH Cochlear Limited | Downgraded: Sell | $210.00 → $95.00 | $114.71 | -17.18% | 15 | Apr 22, 2026 | |
| ASX: PME Pro Medicus Limited | Maintained: Buy | $300.00 → $245.00 | $166.21 | +47.40% | 5 | Apr 6, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Hold | $41.40 → $39.00 | $39.27 | -0.69% | 14 | Mar 30, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Upgraded: Hold | $22.00 → $21.50 | $19.96 | +7.72% | 14 | Mar 19, 2026 | |
| ASX: ANN Ansell Limited | Maintained: Hold | $36.00 | $29.98 | +20.08% | 14 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $31.69 | $20.53 | +54.37% | 4 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €40.00 → €34.00 | $24.58 | n/a | 14 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 86.00 → CHF 84.00 | $118.04 | n/a | 61 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.50 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €118.00 → €103.00 | $73.34 | n/a | 56 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 1,850p → 1,820p | $1,923.00 | n/a | 85 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €95.00 → €87.00 | $249.31 | n/a | 16 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 2,880 → kr 2,600 | $1,614.50 | n/a | 16 | May 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $25.27 | n/a | 1 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $147.08 | n/a | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $390 | $877.72 | n/a | 1 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $86 → $88 | $28.32 | n/a | 5 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €108.00 | $133.05 | n/a | 1 | Feb 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $42.38 | n/a | 1 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $50.67 | n/a | 1 | Feb 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $303 → $300 | $43.19 | n/a | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $96 → $99 | $1,098.57 | n/a | 18 | Jul 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $55 | $54.00 | n/a | 16 | Oct 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 | $123.76 | n/a | 14 | Oct 18, 2017 |
ResMed
Jun 15, 2026
Rated: Buy
Price Target: $340 → $270
Current: $188.63
Upside: +43.14%
ResMed Inc.
Jun 15, 2026
Maintained: Buy
Price Target: $48.00 → $38.00
Current: $26.72
Upside: +42.22%
Fisher & Paykel Healthcare Corporation Limited
May 27, 2026
Maintained: Hold
Price Target: n/a
Current: $38.37
Upside: -
CSL Limited
May 14, 2026
Maintained: Hold
Price Target: $110.00
Current: $111.37
Upside: -1.23%
Telix Pharmaceuticals Limited
Apr 29, 2026
Maintained: Buy
Price Target: $32.00
Current: $14.51
Upside: +120.54%
Cochlear Limited
Apr 22, 2026
Downgraded: Sell
Price Target: $210.00 → $95.00
Current: $114.71
Upside: -17.18%
Pro Medicus Limited
Apr 6, 2026
Maintained: Buy
Price Target: $300.00 → $245.00
Current: $166.21
Upside: +47.40%
Ramsay Health Care Limited
Mar 30, 2026
Maintained: Hold
Price Target: $41.40 → $39.00
Current: $39.27
Upside: -0.69%
Sonic Healthcare Limited
Mar 19, 2026
Upgraded: Hold
Price Target: $22.00 → $21.50
Current: $19.96
Upside: +7.72%
Ansell Limited
Mar 18, 2026
Maintained: Hold
Price Target: $36.00
Current: $29.98
Upside: +20.08%
Feb 25, 2026
Upgraded: Buy
Price Target: $31.69
Current: $20.53
Upside: +54.37%
May 7, 2024
Maintained: Hold
Price Target: €40.00 → €34.00
Current: $24.58
Upside: n/a
Dec 14, 2022
Maintained: Hold
Price Target: CHF 86.00 → CHF 84.00
Current: $118.04
Upside: n/a
Aug 9, 2022
Downgraded: Hold
Price Target: n/a
Current: $13.50
Upside: n/a
Aug 9, 2022
Downgraded: Hold
Price Target: €118.00 → €103.00
Current: $73.34
Upside: n/a
Aug 8, 2022
Maintained: Hold
Price Target: 1,850p → 1,820p
Current: $1,923.00
Upside: n/a
Jun 27, 2022
Maintained: Hold
Price Target: €95.00 → €87.00
Current: $249.31
Upside: n/a
May 20, 2022
Maintained: Buy
Price Target: kr 2,880 → kr 2,600
Current: $1,614.50
Upside: n/a
Mar 16, 2022
Upgraded: Buy
Price Target: n/a
Current: $25.27
Upside: n/a
Nov 5, 2021
Downgraded: Hold
Price Target: n/a
Current: $147.08
Upside: n/a
Jun 18, 2021
Initiated Coverage: Buy
Price Target: $390
Current: $877.72
Upside: n/a
Apr 12, 2021
Maintained: Hold
Price Target: $86 → $88
Current: $28.32
Upside: n/a
Feb 28, 2020
Maintained: Hold
Price Target: €108.00
Current: $133.05
Upside: n/a
Aug 14, 2019
Upgraded: Buy
Price Target: n/a
Current: $42.38
Upside: n/a
Feb 22, 2019
Downgraded: Hold
Price Target: n/a
Current: $50.67
Upside: n/a
Aug 8, 2018
Maintained: Hold
Price Target: $303 → $300
Current: $43.19
Upside: n/a
Jul 25, 2018
Downgraded: Hold
Price Target: $96 → $99
Current: $1,098.57
Upside: n/a
Oct 26, 2017
Rated: Hold
Price Target: $55
Current: $54.00
Upside: n/a
Oct 18, 2017
Rated: Buy
Price Target: $96
Current: $123.76
Upside: n/a